WILMINGTON, MASSACHUSETTS--(Marketwire - October 30, 2007) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, November 6, 2007 at 10:55 a.m. ET at The New York Palace Hotel in New York. Interested investors can access the live audio webcast of the presentation at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website for 14 days following the presentation.
